These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24624330)

  • 1. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
    Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
    Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
    Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
    Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage.
    Sheng H; Spasojevic I; Tse HM; Jung JY; Hong J; Zhang Z; Piganelli JD; Batinic-Haberle I; Warner DS
    J Pharmacol Exp Ther; 2011 Sep; 338(3):906-16. PubMed ID: 21652782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection.
    Gauter-Fleckenstein B; Fleckenstein K; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
    Free Radic Biol Med; 2008 Mar; 44(6):982-9. PubMed ID: 18082148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.
    Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I
    Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.
    Celic T; Španjol J; Bobinac M; Tovmasyan A; Vukelic I; Reboucas JS; Batinic-Haberle I; Bobinac D
    Free Radic Res; 2014 Dec; 48(12):1426-42. PubMed ID: 25185063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
    Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I
    Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
    Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
    Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
    Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I
    Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
    Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
    Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage.
    Gauter-Fleckenstein B; Fleckenstein K; Owzar K; Jiang C; Rebouças JS; Batinic-Haberle I; Vujaskovic Z
    Free Radic Biol Med; 2010 Apr; 48(8):1034-43. PubMed ID: 20096348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fe Porphyrin-Based SOD Mimic and Redox-Active Compound, (OH)FeTnHex-2-PyP
    Li L; Tovmasyan A; Sheng H; Xu B; Sampaio RS; Reboucas JS; Warner DS; Batinic-Haberle I; Spasojevic I
    Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32492872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.
    Batinic-Haberle I; Spasojevic I; Tse HM; Tovmasyan A; Rajic Z; St Clair DK; Vujaskovic Z; Dewhirst MW; Piganelli JD
    Amino Acids; 2012 Jan; 42(1):95-113. PubMed ID: 20473774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.
    Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I
    Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.
    Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
    Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
    Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioprotection of the brain white matter by Mn(III) n-Butoxyethylpyridylporphyrin-based superoxide dismutase mimic MnTnBuOE-2-PyP5+.
    Weitzel DH; Tovmasyan A; Ashcraft KA; Rajic Z; Weitner T; Liu C; Li W; Buckley AF; Prasad MR; Young KH; Rodriguiz RM; Wetsel WC; Peters KB; Spasojevic I; Herndon JE; Batinic-Haberle I; Dewhirst MW
    Mol Cancer Ther; 2015 Jan; 14(1):70-9. PubMed ID: 25319393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.
    Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME
    Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.
    Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I
    Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP
    Leu D; Spasojevic I; Nguyen H; Deng B; Tovmasyan A; Weitner T; Sampaio RS; Batinic-Haberle I; Huang TT
    Redox Biol; 2017 Aug; 12():864-871. PubMed ID: 28454069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.